Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility

[1]  M. Daly,et al.  A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. , 2016, Cancer discovery.

[2]  F. Supek,et al.  The rules and impact of nonsense-mediated mRNA decay in human cancers , 2016, Nature Genetics.

[3]  Yi-Xun Liu,et al.  Androgen receptor in Sertoli cells regulates DNA double-strand break repair and chromosomal synapsis of spermatocytes partially through intercellular EGF-EGFR signaling , 2016, Oncotarget.

[4]  R. Winqvist,et al.  Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility , 2016, PLoS genetics.

[5]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[6]  S. Viville,et al.  Exome sequencing reveals a nonsense mutation in TEX15 causing spermatogenic failure in a Turkish family. , 2015, Human molecular genetics.

[7]  Eliseos J. Mucaki,et al.  FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. , 2015, Human molecular genetics.

[8]  J. Schleutker,et al.  Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer , 2015, Clinical genetics.

[9]  Aniruddh Kashyap,et al.  Germline RECQL mutations are associated with breast cancer susceptibility , 2015, Nature Genetics.

[10]  Yuntao Xie,et al.  Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer , 2015, PLoS genetics.

[11]  Brigitte Rack,et al.  Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Martin Kircher,et al.  Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. , 2015, Cancer discovery.

[13]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[14]  F. Couch,et al.  Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer , 2014, Proceedings of the National Academy of Sciences.

[15]  Kenneth Offit,et al.  Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention , 2014, Science.

[16]  H. Nevanlinna,et al.  Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  H. Pospiech,et al.  Heterozygous mutations in PALB2 cause DNA replication and damage response defects , 2013, Nature Communications.

[18]  T. Kondo,et al.  Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene. , 2013, Tissue antigens.

[19]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[20]  R. Tothill,et al.  Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles , 2012, PLoS genetics.

[21]  Kai Wang,et al.  wANNOVAR: annotating genetic variants for personal genomes via the web , 2012, Journal of Medical Genetics.

[22]  C. Doil,et al.  Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia , 2011, Cell Death and Differentiation.

[23]  J. Schleutker,et al.  Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals , 2011, Breast Cancer Research.

[24]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[25]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[26]  J. Brunet.  Hereditary breast cancer and genetic counseling in young women , 2010, Breast Cancer Research and Treatment.

[27]  A. D’Andrea,et al.  Susceptibility pathways in Fanconi's anemia and breast cancer. , 2010, The New England journal of medicine.

[28]  E. Levy-Lahad,et al.  Fanconi anemia and breast cancer susceptibility meet again , 2010, Nature Genetics.

[29]  Edward S. Miller,et al.  The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage , 2009, Cell.

[30]  Nazneen Rahman,et al.  Genetic predisposition to breast cancer: past, present, and future. , 2008, Annual review of genomics and human genetics.

[31]  Päivi Heikkilä,et al.  NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer , 2008, Nature Genetics.

[32]  K. Mclaughlin,et al.  Mouse TEX15 is essential for DNA double-strand break repair and chromosomal synapsis during male meiosis , 2008, The Journal of cell biology.

[33]  G. Pals,et al.  Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. , 2007, American journal of human genetics.

[34]  Katri Pylkäs,et al.  A recurrent mutation in PALB2 in Finnish cancer families , 2007, Nature.

[35]  J. Kere,et al.  Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer. , 2006, Carcinogenesis.

[36]  J. Benítez,et al.  FANCD2 associated with sporadic breast cancer risk. , 2006, Carcinogenesis.

[37]  A. Mannermaa,et al.  Refinement of the 22q12-q13 Breast Cancer–Associated Region: Evidence of TMPRSS6 as a Candidate Gene in an Eastern Finnish Population , 2006, Clinical Cancer Research.

[38]  Arto Mannermaa,et al.  RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. , 2005, Carcinogenesis.

[39]  Päivi Heikkilä,et al.  Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients , 2005, International journal of cancer.

[40]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[41]  S. Seal,et al.  Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. , 2003, Cancer research.

[42]  T. Boon,et al.  Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia , 2003, International journal of cancer.

[43]  O. Kallioniemi,et al.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.

[44]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[45]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[46]  O. Kallioniemi,et al.  Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites , 2001, British Journal of Cancer.

[47]  K Holli,et al.  Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.

[48]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[49]  H. Nevanlinna,et al.  Familial Breast Cancer in Southern Finland , 2002, Disease markers.

[50]  R. Winqvist,et al.  Evidence of founder mutations in Finnish BRCA1 and BRCA2 families. , 1998, American journal of human genetics.